Approval summary for bortezomib for injection in the treatment of multiple myeloma

Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):3954-64. doi: 10.1158/1078-0432.CCR-03-0781.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Clinical Trial, Phase II
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / therapeutic use*
  • Boronic Acids / therapeutic use*
  • Bortezomib
  • Clinical Trials as Topic
  • Drug Approval*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Models, Chemical
  • Multiple Myeloma / drug therapy*
  • Proteasome Endopeptidase Complex / metabolism
  • Pyrazines / therapeutic use*
  • Time Factors
  • United States
  • United States Food and Drug Administration

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Pyrazines
  • Bortezomib
  • Proteasome Endopeptidase Complex